MedTrace Logo

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes

NCT06046833 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-04-25

No results posted yet for this study

Summary

A pilot study to evaluate and compare glucose metrics using a real-time continuous glucose monitor (FreeStyle Libre 3 sensor) between patients with diabetes and gastroparesis and those with diabetes without gastroparesis.

Conditions

  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus, Type 1
  • Gastroparesis With Diabetes Mellitus

Interventions

DEVICE

FreeStyle Libre 3 continuous glucose monitoring sensor

The Freestyle Libre 3 sensor is a small real-time continuous glucose monitor device that measures glucose levels every minute

OTHER

Nutritional drink

Balanced nutritional drink (Boost plus 8 ounces/237 mL)

Sponsors & Collaborators

  • Samita Garg

    lead OTHER

Principal Investigators

  • Samita Garg, MD · The Cleveland Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-08
Primary Completion
2026-03-31
Completion
2026-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06046833 on ClinicalTrials.gov